InsidersTradesSigma
Aurobindo Pharma Limited: insider trades · India · SEBI (PIT + SAST)
SEBI:aurobindo-pharma-limitedIN·SEBI (PIT + SAST)Mcap 674.0Bn€
Discover the full management transaction log of Aurobindo Pharma Limited, a publicly traded company based in India. Shares are quoted on IN IN, under the supervision of SEBI (PIT + SAST). Market capitalisation: €674bn. The latest transaction was filed on 30 March 2024 — Pledge. Among the most active insiders: RPR SONS ADVISORS PVT.LTD., P.SUNEELA RANI (Jointly holding). All data is free.
168
Insider Decl.
0
Thresholds
€1m
4 ops.
Buy Volume
€11m
65 ops.
Sell Volume
Financial data
FY ended March 2025 · cache
1500.50 €
Income statement
Revenue313.78 Bn€
Gross profit176.37 Bn€56% margin
Net income34.86 Bn€11.1% margin
Balance sheet & cash
Market cap674.02 Bn€
Total debt82.63 Bn€
Free Cash Flow14.05 Bn€
Last declaration on 30 March 2024
Declarations0 total
No declarations found
0 of 0 declarations
About Aurobindo Pharma Limited
Aurobindo Pharma Limited is an Indian pharmaceutical company specializing in the manufacture of generic drugs and pharmaceutical products. It is listed on the Bombay Stock Exchange under the symbol XBOM.